Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937)
Open Access
- 1 April 1998
- journal article
- research article
- Published by Elsevier in Differentiation
- Vol. 63 (1) , 33-42
- https://doi.org/10.1046/j.1432-0436.1998.6310033.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- K-ras modulates the cell cycle via both positive and negative regulatory pathwaysOncogene, 1997
- Modulation of Protein Kinase C Activity and Calcium-Sensitive Isoform Expression in Human Myeloid Leukemia Cells by Bryostatin 1: Relationship to Differentiation and Ara-C-Induced ApoptosisExperimental Cell Research, 1996
- Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21Nature, 1996
- Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.Genes & Development, 1995
- Protein Kinase C-Independent Activation of RAF-1 and Mitogen-Activated Protein Kinase by Leukotriene B4 in Guinea Pig EosinophilsBiochemical and Biophysical Research Communications, 1995
- G1 phase progression: Cycling on cueCell, 1994
- p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21Published by Elsevier ,1994
- E2F: a Link Between the Rb Tumor Suppressor Protein and Viral OncoproteinsScience, 1992
- Two protein kinase C activators, bryostatin-1 and phorbol-12-myristate-13-acetate, have different effects on haemopoietic cell proliferation and differentiationCellular Signalling, 1992
- Establishment and characterization of a human histiocytic lymphoma cell line (U‐937)International Journal of Cancer, 1976